Patterns of Antimicrobial Resistance in Urinary Tract Infection Pathogens: A Descriptive Study from a Paraguayan Hospital

Roger Ayala Noldin; Alejandro D. Sosa-Bernal; Diana Zárate

doi:10.54034/mic.e2551

Authors

Roger Ayala Noldin Universidad del Pacifico, Asunción, Paraguay
Alejandro D. Sosa-Bernal Universidad del Pacífico, Asunción, Paraguay
Diana Zárate Centro Médico Nacional, Hospital Nacional, Itauguá, Paraguay

DOI:

https://doi.org/10.54034/mic.e2551

Keywords:

Urinary Tract Infection, Antimicrobial Resistance, Community-Acquired Infection, Paraguay

Abstract

Introduction: Community-acquired urinary tract infections (UTIs) are a major public health concern due to their high prevalence and increasing antimicrobial resistance. This study aimed to describe the antimicrobial resistance patterns of uropathogens isolated from community-acquired UTIs in a Paraguayan hospital. Methods: A descriptive cross-sectional study was conducted from 2021 to 2023, including 136 patients with confirmed UTIs. Sociodemographic, clinical, and risk factor data were collected. Urine cultures were processed following standard microbiological techniques, and antimicrobial susceptibility testing was performed using the Kirby–Bauer method. Results: Escherichia coli (55.1%) and Klebsiella pneumoniae (19.1%) were the predominant isolates. The most common symptoms were fever (73.5%) and dysuria (63.2%). Among E. coli isolates, high resistance rates were observed to norfloxacin (68.7%) and trimethoprim-sulfamethoxazole (61.5%), while high sensitivity was found to fosfomycin (100%) and nitrofurantoin (95.4%). Extended-spectrum β-lactamase (ESBL) production was detected in 89% of resistant E. coli isolates. K. pneumoniae exhibited resistance to norfloxacin (86%) and ampicillin/sulbactam (75%). Conclusions: E. coli remains the leading uropathogen in community-acquired UTIs, showing high resistance to first-line antibiotics. Continuous local surveillance of antimicrobial susceptibility is essential to guide empirical therapy and reduce the spread of multidrug-resistant organisms.

References

1. Cortés JA, Cano Arenas N, Camero Blanco JD, Valderrama-Rios MC, Díaz Brochero C, Donoso W, et al. Guía de práctica clínica para la infección de vías urinarias complicada. Infectio Rev Asoc Colomb Infectol. 2023;27(1). Disponible en: https://doi.org/10.22354/24223794.1120

2. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection, and treatment options. Nat Rev Microbiol. 2023;21(3):115–128. DOI: 10.1038/nrmicro3432

3. Zarnowski VD, Salazar SA, Zarnowski GA. Infección del tracto urinario adquirida en la comunidad. Rev Méd Sinergia. 2021;6(9):e710. DOI: https://doi.org/10.31434/rms.v6i9.710

4. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison's Principles of Internal Medicine. 20th ed. New York: McGraw-Hill; 2018.

5. Cortés JA, Perdomo D, Morales R, Álvarez CA, Cuervo SI, Leal AL, et al. Guía de práctica clínica sobre diagnóstico y tratamiento de infección de vías urinarias no complicada en mujeres adquirida en la comunidad. Rev Fac Med. 2015; 63(4):565–581. DOI: 10.15446/revfacmed.v63.n4.44185

6. Adam HJ, Golden AR, Karlowsky JA, Baxter MR, Nichol KA, Martin I, et al. Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–15. J Antimicrob Chemother. 2018;73(7):12–19. DOI: 10.1093/jac/dky158

7. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S27–S49. DOI: 10.2337/dc25-S002

8. Iacovelli V, Gaziev G, Topazio L, Bove P, Vespasiani G, Finazzi E. Infecciones nosocomiales del tracto urinario: una revisión. Urología. 2014;81(4):222–227. DOI: 10.5301/uro.5000092

9. Camacho L, Portillo G, Rivera A, Sánchez J, Franco R, Duque R, et al. Multirresistencia, resistencia extendida y panresistencia a antibacterianos en el norte de México. Cir Cir. 2021;89(4):426-434. doi: 10.24875/CIRU.20000304.

10. Aydin A, Ahmed K, Zaman I, Khan MS, Dasgupta P. Recurrent urinary tract infections in women. Int Urogynecol J. 2015;26(6):795–804. DOI: 10.1007/s00192-014-2569-5

11. Choe H-S, Lee S-J, Cho Y-H, Çek M, Tandoðdu Z, Wagenlehner F, et al. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother. 2018;24(4):278–283. DOI: 10.1016/j.jiac.2017.11.013

12. González AC, Terán EA, Durán AA, Alviárez ME. Etiología y perfil de resistencia antimicrobiana en pacientes con infección urinaria adquirida en la comunidad. Rev Inst Nac Hig Rafael Rangel. 2019;50(1–2):4–12. Disponible en: https://inhrr.gob.ve/wp-content/uploads/2022/11/revista_inhrr-2019.pdf

13. Ahmed SS, Shariq A, Alsalloom AA, Babikir IH, Alhomoud BN. Uropathogens and their antimicrobial resistance patterns: relationship with urinary tract infections. Int J Health Sci (Qassim). 2019;13(2):48–55. PMID: 30983946; PMCID: PMC6436442.

14. Bai AD, Bonares MJ, Thrall S, et al. Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia. BMC Infect Dis. 2020;20:781. DOI: 10.1186/s12879-020-05499-1

15. Alrashid S, Ashoor R, Alruhalmi S, Hamed A, Alzahrani S, Al Sayyari A. Urinary tract infection as the diagnosis for admission through the emergency department: its prevalence, seasonality, diagnostic methods, and diagnostic decisions. Cureus. 2022;14(8):e27808. DOI: 10.7759/cureus.27808

16. Taboada E, Dávalos-Ortiz J, Gaona D, Vaída J, Giménez R, Páez L, et al. Resultados de urocultivos en pacientes ambulatorios que acuden a un hospital de referencia de Paraguay. Rev Nac (Itauguá). 2025;17:e1700115. DOI: 10.18004/rdn2025.e1700115

17. Molin Queste C. Infecciones urinarias en personas con discapacidad física que presentan patologías neurológicas, atendidas en un centro de discapacidad de la ciudad de Asunción en 2021–2022. Rev Cient Estud Investig. 2025;14:e837. DOI: 10.26885/rcei.14.e837

18. Gajdács M, Ábrók M, Lázár A, Burián K. Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary-care hospital: a 10-year surveillance study. Medicina (Kaunas). 2019;55(7):356. DOI: 10.3390/medicina55070356

19. Abubaker KT, Anwar KA. Antimicrobial susceptibility and integrons detection among extended-spectrum β-lactamase producing Enterobacteriaceae isolates in patients with urinary tract infection. PeerJ. 2023;11:e15429. DOI: 10.7717/peerj.15429